PUBLIC CONTRACT · 2026
040109242026 - Tildracizumab 200 mg/2 ml sol inj ser 2 ml sc
- Contract value
- €5,213.64
- Signed on
- 5 August 2026
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 15755658PUBLISHED SUBJECT
040109242026 - TILDRACIZUMAB 200 MG/2 ML SOL INJ SER 2 ML SC
Parties involved
- Place of performance
- Portugal, Coimbra, Coimbra
- NUTS region
- PT192 - Região de Coimbra
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- LOGISTA PHARMA · Tax ID 503538108
Values and timeline
- Contract price
- €5,213.64
- Procedure base price
- €5,526.44
- Total effective price
- Not reported on Portal BASE
- Publication date
- 12 October 2026
- Award date
- 3 August 2026
- Signing date
- 5 August 2026
- Performance period
- 148 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 24.º, n.º 1, alínea e), subalínea iii) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 11671010
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.